Category:Dan Burton: Difference between revisions

From UmbraXenu
Jump to navigation Jump to search
No edit summary
No edit summary
Line 83: Line 83:
|
|
*[[:Category:2015|2015]] [[:Category:Psychiatric treatment|Psychiatric treatment]] in [[:Category:21st Century Cures Act|21st Century Cures Act]]
*[[:Category:2015|2015]] [[:Category:Psychiatric treatment|Psychiatric treatment]] in [[:Category:21st Century Cures Act|21st Century Cures Act]]
|- style="vertical-align: top; background:#F5F4F2"
|2015 3rd Quarter
|style="text-align:right;"|$30000
|[[:Category:US Senate|US Senate]]
|[http://disclosures.house.gov/ld/pdfform.aspx?id=300852224 300852224]
|[[:Category:Dan Burton|Dan Burton International LLC]]
|[[:Category:CCHR|CCHR]]
|[[:Category:Dan Burton|Dan Burton]]
|
*Seeking to maintain or increase protection for the public with reference to psychiatric treatments including drugs and brain devices in H. R. 6 - 21st Century Cures Act and it its Senate counterpart (not yet introduced).
|- style="vertical-align: top; background:#F5F4F2"
|- style="vertical-align: top; background:#F5F4F2"
|2015 4th Quarter
|2015 4th Quarter
Line 93: Line 103:
|
|
*[[:Category:2015|2015]] [[:Category:Psychiatric treatment|Psychiatric treatment]] in [[:Category:21st Century Cures Act|21st Century Cures Act]]
*[[:Category:2015|2015]] [[:Category:Psychiatric treatment|Psychiatric treatment]] in [[:Category:21st Century Cures Act|21st Century Cures Act]]
|- style="vertical-align: top; background:#F5F4F2"
|2015 4th Quarter
|style="text-align:right;"|$30000
|[[:Category:US Senate|US Senate]]
|[http://disclosures.house.gov/ld/pdfform.aspx?id=300852220 300852220]
|[[:Category:Dan Burton|Dan Burton International LLC]]
|[[:Category:CCHR|CCHR]]
|[[:Category:Dan Burton|Dan Burton]]
|
*Seeking to maintain or increase protection for the public with reference to psychiatric treatments including drugs and brain devices in H. R. 6 - 21st Century Cures Act and it its Senate counterpart (not yet introduced).
|- style="vertical-align: top; background:#F5F4F2"
|- style="vertical-align: top; background:#F5F4F2"
|2016 1st Quarter
|2016 1st Quarter
Line 108: Line 128:
*[[:Category:2016|2016]], [[:Category:Mental Health Reform Act of 2016|Mental Health Reform Act of 2016]]
*[[:Category:2016|2016]], [[:Category:Mental Health Reform Act of 2016|Mental Health Reform Act of 2016]]
*[[:Category:2014|2014]], [[:Category:FDA|FDA]] [[:Category:Electroconvulsive Therapy (ECT)|Electroconvulsive Therapy]] classification under [[:Category: FDA Proposed Rule Change on Electroconvulsive Therapy (ECT)|ECT Proposed Rule Change]]
*[[:Category:2014|2014]], [[:Category:FDA|FDA]] [[:Category:Electroconvulsive Therapy (ECT)|Electroconvulsive Therapy]] classification under [[:Category: FDA Proposed Rule Change on Electroconvulsive Therapy (ECT)|ECT Proposed Rule Change]]
|- style="vertical-align: top; background:#F5F4F2"
|2016 1st Quarter
|style="text-align:right;"|$20000
|[[:Category:US House of Representatives|US House of Representatives]], [[:Category:US Senate|US Senate]]
|[http://disclosures.house.gov/ld/pdfform.aspx?id=300815526 300815526]
|[[:Category:Dan Burton|Dan Burton International LLC]]
|[[:Category:CCHR|CCHR]]
|[[:Category:Dan Burton|Dan Burton]]
|
*Seeking to maintain or increase protection for the public with reference to psychiatric treatments including drugs and brain devices in H. R. 6 - 21st Century Cures Act, in H. R. 2646 - Helping Families in Mental Health Crisis and in S. 1077 - Advancing Breakthrough Devices For Patients Act of 2015.
*
*Opposition to FDA Proposed Rule on electroconvulsive therapy (ECT) devices.
|- style="vertical-align: top; background:#F5F4F2"
|2016 1st Quarter
|style="text-align:right;"|$30000
|[[:Category:US House of Representatives|US House of Representatives]], [[:Category:US Senate|US Senate]]
|[http://disclosures.house.gov/ld/pdfform.aspx?id=300852217 300852217]
|[[:Category:Dan Burton|Dan Burton International LLC]]
|[[:Category:CCHR|CCHR]]
|[[:Category:Dan Burton|Dan Burton]]
|
*Seeking to maintain or increase protection for the public with reference to psychiatric treatments including drugs and brain devices in H. R. 6 - 21st Century Cures Act, in H. R. 2646 - Helping Families in Mental Health Crisis and in S. 1077 - Advancing Breakthrough Devices For Patients Act of 2015.
*
*Opposition to FDA Proposed Rule on electroconvulsive therapy (ECT) devices.
|- style="vertical-align: top; background:#F5F4F2"
|- style="vertical-align: top; background:#F5F4F2"
|2016 2nd Quarter
|2016 2nd Quarter
Line 123: Line 167:
*[[:Category:2016|2016]], [[:Category:Mental Health Reform Act of 2016|Mental Health Reform Act of 2016]]
*[[:Category:2016|2016]], [[:Category:Mental Health Reform Act of 2016|Mental Health Reform Act of 2016]]
*[[:Category:2014|2014]], [[:Category:FDA|FDA]] [[:Category:Electroconvulsive Therapy (ECT)|Electroconvulsive Therapy]] classification under [[:Category: FDA Proposed Rule Change on Electroconvulsive Therapy (ECT)|ECT Proposed Rule Change]]
*[[:Category:2014|2014]], [[:Category:FDA|FDA]] [[:Category:Electroconvulsive Therapy (ECT)|Electroconvulsive Therapy]] classification under [[:Category: FDA Proposed Rule Change on Electroconvulsive Therapy (ECT)|ECT Proposed Rule Change]]
|- style="vertical-align: top; background:#F5F4F2"
|2016 2nd Quarter
|style="text-align:right;"|$30000
|[[:Category:US House of Representatives|US House of Representatives]], [[:Category:US Senate|US Senate]]
|[http://disclosures.house.gov/ld/pdfform.aspx?id=300852213 300852213]
|[[:Category:Dan Burton|Dan Burton International LLC]]
|[[:Category:CCHR|CCHR]]
|[[:Category:Dan Burton|Dan Burton]]
|
*Seeking to maintain or increase protection for the public with reference to psychiatric treatments including drugs and brain devices in H. R. 6 - 21st Century Cures Act, in House Appropriations Subcommittee Bill on Agriculture, Rural Development, Food and Drug Administration, and Related Agencies for FY 2017 (containing provisions of H. R. 6), in H. R. 2646 - Helping Families in Mental Health Crisis in S. 1077 - Advancing Breakthrough Devices For Patients Act of 2015, in S. 2680 - Mental Health Reform Act of 2016 and in FDA Proposed Rule on Electroconvulsive Therapy (ECT).
|- style="vertical-align: top; background:#F5F4F2"
|- style="vertical-align: top; background:#F5F4F2"
|2016 3rd Quarter
|2016 3rd Quarter
Line 138: Line 192:
*[[:Category:2016|2016]], [[:Category:Mental Health Reform Act of 2016|Mental Health Reform Act of 2016]]
*[[:Category:2016|2016]], [[:Category:Mental Health Reform Act of 2016|Mental Health Reform Act of 2016]]
*[[:Category:2014|2014]], [[:Category:FDA|FDA]] [[:Category:Electroconvulsive Therapy (ECT)|Electroconvulsive Therapy]] classification under [[:Category: FDA Proposed Rule Change on Electroconvulsive Therapy (ECT)|ECT Proposed Rule Change]]
*[[:Category:2014|2014]], [[:Category:FDA|FDA]] [[:Category:Electroconvulsive Therapy (ECT)|Electroconvulsive Therapy]] classification under [[:Category: FDA Proposed Rule Change on Electroconvulsive Therapy (ECT)|ECT Proposed Rule Change]]
|- style="vertical-align: top; background:#F5F4F2"
|2016 3rd Quarter
|style="text-align:right;"|$30000
|[[:Category:US House of Representatives|US House of Representatives]], [[:Category:US Senate|US Senate]]
|[http://disclosures.house.gov/ld/pdfform.aspx?id=300852210 300852210]
|[[:Category:Dan Burton|Dan Burton International LLC]]
|[[:Category:CCHR|CCHR]]
|[[:Category:Dan Burton|Dan Burton]]
|
*Seeking to maintain or increase protection for the public with reference to psychiatric treatments including drugs and brain devices in H. R. 6 - 21st Century Cures Act, in House Appropriations Subcommittee Bill on Agriculture, Rural Development, Food and Drug Administration, and Related Agencies for FY 2017 (containing provisions of H. R. 6), in H. R. 2646 - Helping Families in Mental Health Crisis in S. 1077 - Advancing Breakthrough Devices For Patients Act of 2015, in S. 2680 - Mental Health Reform Act of 2016 and in FDA Proposed Rule on Electroconvulsive Therapy (ECT).
|- style="vertical-align: top; background:#F5F4F2"
|2016 4th Quarter
|style="text-align:right;"|$30000
|[[:Category:US House of Representatives|US House of Representatives]], [[:Category:US Senate|US Senate]]
|[http://disclosures.house.gov/ld/pdfform.aspx?id=300852195 300852195]
|[[:Category:Dan Burton|Dan Burton International LLC]]
|[[:Category:CCHR|CCHR]]
|[[:Category:Dan Burton|Dan Burton]]
|
*[[:Category:2015|2015]] [[:Category:Psychiatric treatment|Psychiatric treatment]] in [[:Category:21st Century Cures Act|21st Century Cures Act]]
|- style="vertical-align: top; background:#F5F4F2"
|2017 1st Quarter
|style="text-align:right;"|$30000
|[[:Category:US House of Representatives|US House of Representatives]], [[:Category:US Senate|US Senate]], [[:Category:US Department of Health and Human Services|US Department of Health and Human Services]]
|[http://disclosures.house.gov/ld/pdfform.aspx?id=300865947 300865947]
|[[:Category:Dan Burton|Dan Burton International LLC]]
|[[:Category:CCHR|CCHR]]
|[[:Category:Dan Burton|Dan Burton]]
|
*[[:Category:2015|2015]] [[:Category:Psychiatric treatment|Psychiatric treatment]] in [[:Category:21st Century Cures Act|21st Century Cures Act]]
|}
|}
<!-- End lobbyist tables -->
<!-- End lobbyist tables -->

Revision as of 17:03, 19 May 2017

Dan Burton
Born Danny Lee Burton
(1938-06-21) June 21, 1938 (age 86)
Indianapolis, Indiana
Residence Indianapolis, Indiana
Alma mater Cincinnati Christian University
Occupation Lobbyist
Political party Republican
Religion Christian churches and churches of Christ
Spouse(s)
  • Barbara J. Logan Burton (?-2002)
  • Samia Tawil (2006-Present)
Dan Burton International, LLC
Formation January 22, 2013 (2013-01-22)
Jurisdiction us-in
Registration no. 2013012400212
Headquarters 12141 E 79th ST, Indianapolis, IN, 46236, USA
John T. Doolittle, LLC
Formation May 5, 2011 (2011-05-05)
Jurisdiction us-va
Registration no. S3634203

Lobbyist activity

CCHR

Year/Period Income Agencies lobbied Doc ID Firm Client Lobbyist Issues
2015 3rd Quarter $20000 US Senate 300755227 Dan Burton International LLC CCHR Dan Burton
2015 3rd Quarter $30000 US Senate 300852224 Dan Burton International LLC CCHR Dan Burton
  • Seeking to maintain or increase protection for the public with reference to psychiatric treatments including drugs and brain devices in H. R. 6 - 21st Century Cures Act and it its Senate counterpart (not yet introduced).
2015 4th Quarter $20000 US Senate 300783931 Dan Burton International LLC CCHR Dan Burton
2015 4th Quarter $30000 US Senate 300852220 Dan Burton International LLC CCHR Dan Burton
  • Seeking to maintain or increase protection for the public with reference to psychiatric treatments including drugs and brain devices in H. R. 6 - 21st Century Cures Act and it its Senate counterpart (not yet introduced).
2016 1st Quarter $20000 US House of Representatives, US Senate 300796968 Dan Burton International LLC CCHR Dan Burton
2016 1st Quarter $20000 US House of Representatives, US Senate 300815526 Dan Burton International LLC CCHR Dan Burton
  • Seeking to maintain or increase protection for the public with reference to psychiatric treatments including drugs and brain devices in H. R. 6 - 21st Century Cures Act, in H. R. 2646 - Helping Families in Mental Health Crisis and in S. 1077 - Advancing Breakthrough Devices For Patients Act of 2015.
  • Opposition to FDA Proposed Rule on electroconvulsive therapy (ECT) devices.
2016 1st Quarter $30000 US House of Representatives, US Senate 300852217 Dan Burton International LLC CCHR Dan Burton
  • Seeking to maintain or increase protection for the public with reference to psychiatric treatments including drugs and brain devices in H. R. 6 - 21st Century Cures Act, in H. R. 2646 - Helping Families in Mental Health Crisis and in S. 1077 - Advancing Breakthrough Devices For Patients Act of 2015.
  • Opposition to FDA Proposed Rule on electroconvulsive therapy (ECT) devices.
2016 2nd Quarter $20000 US House of Representatives, US Senate 300815294 Dan Burton International LLC CCHR Dan Burton
2016 2nd Quarter $30000 US House of Representatives, US Senate 300852213 Dan Burton International LLC CCHR Dan Burton
  • Seeking to maintain or increase protection for the public with reference to psychiatric treatments including drugs and brain devices in H. R. 6 - 21st Century Cures Act, in House Appropriations Subcommittee Bill on Agriculture, Rural Development, Food and Drug Administration, and Related Agencies for FY 2017 (containing provisions of H. R. 6), in H. R. 2646 - Helping Families in Mental Health Crisis in S. 1077 - Advancing Breakthrough Devices For Patients Act of 2015, in S. 2680 - Mental Health Reform Act of 2016 and in FDA Proposed Rule on Electroconvulsive Therapy (ECT).
2016 3rd Quarter $20000 US House of Representatives, US Senate 300830023 Dan Burton International LLC CCHR Dan Burton
2016 3rd Quarter $30000 US House of Representatives, US Senate 300852210 Dan Burton International LLC CCHR Dan Burton
  • Seeking to maintain or increase protection for the public with reference to psychiatric treatments including drugs and brain devices in H. R. 6 - 21st Century Cures Act, in House Appropriations Subcommittee Bill on Agriculture, Rural Development, Food and Drug Administration, and Related Agencies for FY 2017 (containing provisions of H. R. 6), in H. R. 2646 - Helping Families in Mental Health Crisis in S. 1077 - Advancing Breakthrough Devices For Patients Act of 2015, in S. 2680 - Mental Health Reform Act of 2016 and in FDA Proposed Rule on Electroconvulsive Therapy (ECT).
2016 4th Quarter $30000 US House of Representatives, US Senate 300852195 Dan Burton International LLC CCHR Dan Burton
2017 1st Quarter $30000 US House of Representatives, US Senate, US Department of Health and Human Services 300865947 Dan Burton International LLC CCHR Dan Burton

See also

External links

Subcategories

This category has the following 4 subcategories, out of 4 total.

2

B

F

J

Media in category "Dan Burton"

The following 2 files are in this category, out of 2 total.

Retrieved from "http://192.168.1.3/mediawiki/index.php?title=Category:Dan_Burton&oldid=90083"